Author

F. Tu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Cell Biology· 1 Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:proteomics· 3 Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

Z. Yang· 2 shared A. White· 1 shared B. Werner· 1 shared C. Zhang· 1 shared D. GU· 1 shared E. Marcotte· 1 shared F. Ren· 1 shared F. Xu· 1 shared

Activity by Year

2017-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Z. Yang

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Mutation divergence over space in tumour expansion

H. Li, F. Tu, L. Deng, Z. Yang, X. Fu, L. Wang, D. GU, B. Werner, W. Huang

This study quantifies how mutation divergence varies with sampling distance and tumour expansion modes using simulations, showing that mutation rate inference is less accurate with smaller sampling sizes and slower expansion.

Journal of The Royal Society Interface · Nov 1, 2023Peer-reviewedCancer Biology

Nifuroxazide Suppresses PD-L1 Expression and Enhances the Efficacy of Radiotherapy in Hepatocellular Carcinoma

T. Zhao, P. Wei, C. Zhang, S. Zhou, L. Liang, S. Guo, Z. Yin, S. Cheng, Z. Gan, Y. Xia, Y. Zhang, S. Guo, J. Zhong, Z. Yang, F. Tu, , H. Jia

This study shows nifuroxazide enhances radiotherapy in HCC by reducing PD-L1 expression and improving tumor response.

bioRxiv · Sep 3, 2023 · PreprintImmunology

Machine learning and hypothesis driven optimization of bull semen cryopreservation media

F. Tu, M. Bhat, P. Blondin, P. Vincent, M. Sharafi, J. D. Benson

This paper uses machine learning to optimize bull semen cryopreservation media, improving post-thaw motility from 52.6% to 68.3%.

bioRxiv · Sep 27, 2022Bioengineering

Using NAMs to characterize chemical bioactivity at the transcriptomic, proteomic and phosphoproteomic levels

Y. Li, Z. zhang, S. Jiang, F. Xu, L. Tulum, K. Li, S. Liu, S. Li, L. Chang, M. Liddell, F. Tu, X. Gu, P. L. Carmichael, A. White, S. Peng, , P. Xu

This paper integrates multi-omic data to characterize chemical bioactivity at transcriptomic, proteomic, and phosphoproteomic levels, showing how early phosphoproteomic changes drive downstream effects.

bioRxiv · May 18, 2022 · PreprintPharmacology & Toxicology

High-content protein localization screening in vivo reveals novel regulators of multiciliated cell development and function

F. Tu, J. Sedzinski, Y. Ma, E. Marcotte, J. Wallingford

The paper screens 260 poorly characterized proteins in multiciliated cells to identify novel regulators of their development and function.

bioRxiv · May 23, 2017Cell Biology